Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579813 · ClinicalTrials.gov registry record · Phase 4
Mechanisms Underlying Metabolic Syndrome in Obesity
A Phase 4 study, sponsored by Philip Kern.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00579813: Completed Phase 4 study, sponsored by Philip Kern.
NCT00579813 is a Phase 4 study that has completed, run by Philip Kern. The registered enrollment target is 70 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579813, a Phase 4 study, has completed, sponsored by Philip Kern.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the link between obesity and diabetes or pre-diabetes.
Primary Outcome
The frequently sampled intravenous glucose tolerance test (FSIGT) involves the injection of IV glucose and the frequent measurement of glucose and insulin.
Interventions
- DRUG Pioglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2005-04 |
| Est. Completion | 2011-01 |
| Phase | Phase 4 |
What the finished NCT00579813 record still lists
NCT00579813 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Pioglitazone is the first listed.
NCT00579813 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00579813 about?
NCT00579813 is a clinical study titled "Mechanisms Underlying Metabolic Syndrome in Obesity". The purpose of this study is to better understand the link between obesity and diabetes or pre-diabetes.
What is the current status of trial NCT00579813?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2005-04. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00579813?
The interventions under investigation include: Pioglitazone (DRUG).
Who is sponsoring clinical trial NCT00579813?
This trial is sponsored by Philip Kern, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00579813's enrollment target sits among peer trials
70 1043rd of 2000 higher than 931 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia